(Q72852195)

English

Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion

scientific article published on 01 January 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Etienne Chatelut

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

C Muller

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

V Gualano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M De Forni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F Huguet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Attal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

P Canal

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

G Laurent

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

379-384

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Clinical evaluation of long-term, continuous-infusion doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular Pharmacokinetics of Doxorubicin in Cultured Mouse Sarcoma Cells Originating from Autochthonous Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronopharmacokinetics of doxorubicin in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of malignant lymphomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8339389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00735923

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339389%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72852195&oldid=2222712675"